These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36212077)

  • 21. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
    Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
    J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
    Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
    Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
    Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
    Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH Sensitive Triptolide-Loaded Liposome Calcium Phosphate Nanoparticles Exhibit Enhanced Anti-Tumor Activities Against Ovarian Cancer Without Damaging the Reproductive System.
    Ru D; Ding C; Liu L; Liu H; Shen M; Duan Y; Li H
    J Biomed Nanotechnol; 2017 Nov; 13(11):1413-1424. PubMed ID: 31271128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment.
    Wang X; Zeng H; Zhu X; Xu D; Tian Q; Wang C; Zhao L; Zhao J; Miao M; Wu X
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer.
    Yuan F; Sun M; Liu Z; Liu H; Kong W; Wang R; Qian F
    Theranostics; 2022; 12(3):1061-1073. PubMed ID: 35154474
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategy for osteoarthritis therapy: Improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays.
    Zhou P; Chen C; Yue X; Zhang J; Huang C; Zhao S; Wu A; Li X; Qu Y; Zhang C
    Int J Pharm; 2021 Nov; 609():121211. PubMed ID: 34687817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
    Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
    Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
    Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
    Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-Delivery of Triptolide and Curcumin for Ovarian Cancer Targeting Therapy via mPEG-DPPE/CaP Nanoparticle.
    Liu L; Xiong X; Shen M; Ru D; Gao P; Zhang X; Huang C; Sun Y; Li H; Duan Y
    J Biomed Nanotechnol; 2018 Oct; 14(10):1761-1772. PubMed ID: 30041722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.
    Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.
    Biswas S; Dodwadkar NS; Deshpande PP; Torchilin VP
    J Control Release; 2012 May; 159(3):393-402. PubMed ID: 22286008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
    Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
    Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
    Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
    Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes.
    Feng Y; Qin G; Chang S; Jing Z; Zhang Y; Wang Y
    Int J Nanomedicine; 2021; 16():3073-3089. PubMed ID: 33953556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
    Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
    Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a Multifunctional Nano-Scale Metal-Organic Framework-Based Drug Delivery System for Targeted Cancer Therapy.
    Cai M; Zeng Y; Liu M; You L; Huang H; Hao Y; Yin X; Qu C; Ni J; Dong X
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
    Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
    Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.